Next Article in Journal
The Effect of Education through Short Message Service (SMS) Messages on Diabetic Patients Adherence
Previous Article in Journal
Kurzfassungen der Vorträge und Poster der 21. Wissenschaftlichen Tagung der Österreichischen Pharmazeutischen Gesellschaft (ÖPhG), 16. bis 18. April 2009, Wien, Österreich
Article Menu

Article Versions

Export Article

Open AccessAbstract
Sci. Pharm. 2009, 77(Plenary Lectures (PL)), 163; doi:10.3797/scipharm.oephg.21.PL-01 (registering DOI)

Gender Medicine and Frankincense: Novel Findings in Inflammation Research

Department of Pharmaceutical Analytics, Pharmaceutical Institute, Univ. Tuebingen, Auf der Morgenstelle 8, 72076 Tuebingen, Germany
Received: 16 April 2009 / Accepted: 16 April 2009 / Published: 16 April 2009
Download PDF [214 KB, uploaded 11 May 2017]

Abstract

Detailed insights into the pathobiochemical mechanisms of the inflammatory process and the molecular actions of anti-inflammatory drugs are determinants for successful intervention with inflammatory diseases. Gender differences regarding susceptibility to inflammatory diseases are well known, for example rheumatoid arthritis and systemic lupus erythematosus more often affect women. In asthma, sex differences are apparent with a male predominance in childhood, whereas after puberty females predominate, due to a drop in males, reflecting a protective function of androgens. However, the biochemical mechanisms underlying these gender disparities are not understood. Leukotrienes, generated by the 5-lipoxygenase (5-LO) pathway, are involved in inflammatory and allergic disorders, and leukotriene receptor antagonists are used in asthma therapy. We found that leukotriene formation is substantially higher in females versus males, accompanied by different 5-LO trafficking, due to male-specific activation of extracellular signal-regulated kinases (ERKs). The differences are directly related to male/female testosterone levels. Our data suggest that gender issues should be considered in the use of anti-leukotrienes as therapeutics to optimize pharmacological therapy, in men and women. The anti-inflammatory properties of frankincense, the gum resin derived from Boswellia species, are well-recognized. Boswellic acids (BAs) are major ingredients of frankincense that were shown to inhibit 5-LO in vitro, but recent data question the pharmacological relevance of such interference in vivo. We report about the identification of human cathepsin G as pharmacologically relevant target of BAs. In particular, the major naturally occurring β-BA, reaching pharmacological relevant plasma levels (6.5–10 μM) after oral intake of medical frankincense preparations, potently inhibits cathepsin G in vitro and ex vivo, and exhibits high efficacy in animal models of inflammation, supporting an anti-inflammatory efficacy of frankincense in patients.
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

WERZ, O. Gender Medicine and Frankincense: Novel Findings in Inflammation Research. Sci. Pharm. 2009, 77, 163.

Show more citation formats Show less citations formats

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Sci. Pharm. EISSN 2218-0532 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top